Literature DB >> 23090112

Using USP I and USP IV for discriminating dissolution rates of nano- and microparticle-loaded pharmaceutical strip-films.

Lucas Sievens-Figueroa1, Natasha Pandya, Anagha Bhakay, Golshid Keyvan, Bozena Michniak-Kohn, Ecevit Bilgili, Rajesh N Davé.   

Abstract

Recent interest in the development of drug particle-laden strip-films suggests the need for establishing standard regulatory tests for their dissolution. In this work, we consider the dissolution testing of griseofulvin (GF) particles, a poorly water-soluble compound, incorporated into a strip-film dosage form. The basket apparatus (USP I) and the flow-through cell dissolution apparatus (USP IV) were employed using 0.54% sodium dodecyl sulfate as the dissolution medium as per USP standard. Different rotational speeds and dissolution volumes were tested for the basket method while different cell patterns/strip-film position and dissolution media flow rate were tested using the flow-through cell dissolution method. The USP I was not able to discriminate dissolution of GF particles with respect to particle size. On the other hand, in the USP IV, GF nanoparticles incorporated in strip-films exhibited enhancement in dissolution rates and dissolution extent compared with GF microparticles incorporated in strip-films. Within the range of patterns and flow rates used, the optimal discrimination behavior was obtained when the strip-film was layered between glass beads and a flow rate of 16 ml/min was used. These results demonstrate the superior discriminatory power of the USP IV and suggest that it could be employed as a testing device in the development of strip-films containing drug nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090112      PMCID: PMC3513447          DOI: 10.1208/s12249-012-9875-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  30 in total

Review 1.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

Authors:  R H Müller; C Jacobs; O Kayser
Journal:  Adv Drug Deliv Rev       Date:  2001-03-23       Impact factor: 15.470

2.  Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus.

Authors:  Shobha N Bhattachar; James A Wesley; Ann Fioritto; Peter J Martin; Suresh R Babu
Journal:  Int J Pharm       Date:  2002-04-02       Impact factor: 5.875

Review 3.  Nanosizing: a formulation approach for poorly-water-soluble compounds.

Authors:  Elaine Merisko-Liversidge; Gary G Liversidge; Eugene R Cooper
Journal:  Eur J Pharm Sci       Date:  2003-02       Impact factor: 4.384

Review 4.  Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs.

Authors:  Jiahui Hu; Keith P Johnston; Robert O Williams
Journal:  Drug Dev Ind Pharm       Date:  2004-03       Impact factor: 3.225

5.  A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.

Authors:  Yimin Wang; Piero M Armenante
Journal:  J Pharm Sci       Date:  2011-11-14       Impact factor: 3.534

6.  Comparative dissolution studies of rectal formulations using the Basket, the Paddle and the Flow-Through methods. I. Paracetamol in suppositories and soft gelatin capsules of both hydrophilic and lipophilic types.

Authors:  K Gjellan; C Graffner
Journal:  Acta Pharm Nord       Date:  1989

7.  A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.

Authors:  V M Rao; M Lin; C K Larive; M Z Southard
Journal:  J Pharm Sci       Date:  1997-10       Impact factor: 3.534

8.  Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens.

Authors:  Cherng-Yih Perng; Albert S Kearney; Nagesh R Palepu; Brian R Smith; Leonard M Azzarano
Journal:  Int J Pharm       Date:  2003-01-02       Impact factor: 5.875

9.  Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.

Authors:  Lucas Sievens-Figueroa; Anagha Bhakay; Jackeline I Jerez-Rozo; Natasha Pandya; Rodolfo J Romañach; Bozena Michniak-Kohn; Zafar Iqbal; Ecevit Bilgili; Rajesh N Davé
Journal:  Int J Pharm       Date:  2011-12-09       Impact factor: 5.875

10.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

View more
  13 in total

1.  Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading.

Authors:  Scott M Krull; Jacqueline Moreno; Meng Li; Ecevit Bilgili; Rajesh N Davé
Journal:  Int J Pharm       Date:  2017-03-16       Impact factor: 5.875

2.  Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.

Authors:  Scott M Krull; Hardik V Patel; Meng Li; Ecevit Bilgili; Rajesh N Davé
Journal:  Eur J Pharm Sci       Date:  2016-07-08       Impact factor: 4.384

Review 3.  Improved delivery of poorly soluble compounds using nanoparticle technology: a review.

Authors:  Sandeep Kalepu; Vijaykumar Nekkanti
Journal:  Drug Deliv Transl Res       Date:  2016-06       Impact factor: 4.617

4.  Zero-order release of poorly water-soluble drug from polymeric films made via aqueous slurry casting.

Authors:  Lu Zhang; Joy Alfano; Doran Race; Rajesh N Davé
Journal:  Eur J Pharm Sci       Date:  2018-02-27       Impact factor: 4.384

5.  Impact of Superdisintegrants and Film Thickness on Disintegration Time of Strip Films Loaded With Poorly Water-Soluble Drug Microparticles.

Authors:  Lu Zhang; Marie Aloia; Barbara Pielecha-Safira; Honghao Lin; Prarthana Manoj Rajai; Kuriakose Kunnath; Rajesh N Davé
Journal:  J Pharm Sci       Date:  2018-04-14       Impact factor: 3.534

6.  Assessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System.

Authors:  Diego Fontana de Andrade; Carine Zuglianello; Adriana Raffin Pohlmann; Silvia Stanisçuaski Guterres; Ruy Carlos Ruver Beck
Journal:  AAPS PharmSciTech       Date:  2015-05-19       Impact factor: 3.246

7.  Decoding Fine API Agglomeration as a Key Indicator of Powder Flowability and Dissolution: Impact of Particle Engineering.

Authors:  Sangah Kim; Mirna Cheikhali; Rajesh N Davé
Journal:  Pharm Res       Date:  2022-06-14       Impact factor: 4.200

Review 8.  In vitro dissolution considerations associated with nano drug delivery systems.

Authors:  Ritu Gupta; Yuan Chen; Huan Xie
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-06-15

9.  Effect of solvents and cellulosic polymers on quality attributes of films loaded with a poorly water-soluble drug.

Authors:  Eylul Cetindag; John Pentangelo; Thierry Arrieta Cespedes; Rajesh N Davé
Journal:  Carbohydr Polym       Date:  2020-08-29       Impact factor: 9.381

10.  Impact of Mixing on Content Uniformity of Thin Polymer Films Containing Drug Micro-Doses.

Authors:  Guluzar G Buyukgoz; Jeremiah N Castro; Andrew E Atalla; John G Pentangelo; Siddharth Tripathi; Rajesh N Davé
Journal:  Pharmaceutics       Date:  2021-05-29       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.